Social Media Data for Real World Evidence in Regulatory Decision Making
Submitted by Anonymous (not verified) on 15 November 2024 - 9:12
Social Media Data for Real World Evidence in Regulatory Decision Making
Article 57 product data
Submitted by Anonymous (not verified) on 15 November 2024 - 9:05
Article 57 product data
EMEA-003474-PIP01-23
Submitted by Anonymous (not verified) on 14 November 2024 - 15:57
EMEA-003474-PIP01-23
EMEA-003482-PIP01-23
Submitted by Anonymous (not verified) on 14 November 2024 - 15:56
EMEA-003482-PIP01-23
Opinion/decision on a Paediatric investigation plan (PIP): Tezspire, tezepelumab, decision type: P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s), therapeutic area: Gastroentology-Hepatology, PIP number: P
Submitted by Anonymous (not verified) on 14 November 2024 - 15:55
Opinion/decision on a Paediatric investigation plan (PIP): Tezspire, tezepelumab, decision type: P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s), therapeutic area: Gastroentology-Hepatology, PIP number: P/0407/2023
Leqembi recommended for treatment of early Alzheimer’s disease
Submitted by Anonymous (not verified) on 14 November 2024 - 15:55
Leqembi recommended for treatment of early Alzheimer’s disease
EMEA-003442-PIP01-23
Submitted by Anonymous (not verified) on 14 November 2024 - 15:54
EMEA-003442-PIP01-23
EMEA-002721-PIP04-23
Submitted by Anonymous (not verified) on 14 November 2024 - 15:53
EMEA-002721-PIP04-23
Quality Review of Documents (QRD) working group plenary meeting dates
Submitted by Anonymous (not verified) on 14 November 2024 - 15:10
Quality Review of Documents (QRD) working group plenary meeting dates
Minutes of the CAT meeting 11-12 September 2024
Submitted by Anonymous (not verified) on 14 November 2024 - 11:28
Minutes of the CAT meeting 11-12 September 2024